前列腺癌治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2030 年

  • Report Code : TIPRE00021050
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Prostate Cancer Treatment Market to 2030 - Trends, Share, Size

Buy Now

【研究报告】前列腺癌治疗市场规模预计将从2022年的190.7亿美元增长到2030年的341.1亿美元;预计 2022 年至 2030 年市场复合年增长率为 7.5%。

市场洞察和分析师观点:

前列腺癌患者可以获得不同类型的治疗。有些治疗是标准的(目前正在使用的),而有些则处于临床试验阶段。市场增长归因于为引入新药物化合物而进行的研发活动不断增加、前列腺癌病例数量激增以及政府对鼓励前列腺癌筛查和诊断的支持不断增加。尽管世界发达地区有多种治疗方法,但治疗成本很高,这限制了前列腺癌治疗市场的增长,特别是在发展中国家和不发达国家。

增长动力和挑战:
< br>前列腺癌是男性最常见的健康问题之一,尤其是50岁及以上的老年男性。它最常见于肥胖男性和有前列腺癌家族史的人。这种疾病是一种无声的威胁,因为它通常在没有明显症状的情况下发展。因此,这种疾病很难在早期发现。大多数前列腺癌起源于前列腺的周围区域。任何 50 岁或以上出现下尿路症状、勃起功能障碍或血尿的人都应考虑前列腺癌的可能性。前列腺癌在全球男性癌症相关死亡的主要原因中排名第五,在最常见的癌症类型中排名第二。即使2000年以来前列腺癌的发病率有所下降,但从2010年开始,晚期前列腺癌的发病率却有所上升。发达国家的前列腺癌发病率普遍较高,但死亡率较低。美国患前列腺癌的风险几乎是全球风险的四倍。据诺华公司称,2020 年全球报告了约 140 万前列腺癌新病例和近 375,000 例前列腺癌死亡病例。前列腺癌病例数量激增,加上检出率低,推动了前列腺癌治疗市场的增长。此外,靶向治疗的日益普及预计将在未来几年带来新的前列腺癌治疗市场趋势。



报告细分和范围:

前列腺癌症治疗市场分析是通过考虑以下部分进行的:治疗类型、最终用户和地理位置。按治疗类型划分,市场分为手术、放射治疗、激素治疗、化疗、免疫治疗、靶向治疗等。根据最终用户,市场分为医院、诊所等。从地域来看,前列腺癌治疗市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、日本、印度、澳大利亚和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和其他地区)南美洲和中美洲)。

细分分析:

按治疗类型,市场分为手术、放射治疗、激素治疗、化疗、免疫治疗、靶向治疗等。 2022年,化疗领域占据最大的前列腺癌治疗市场份额。激素治疗领域预计将在 2022 年至 2030 年期间创下最高复合年增长率。前列腺癌治疗期间规定的激素疗法可阻止体内睾酮的释放。睾酮有助于促进体内前列腺癌细胞的生长。激素疗法优选用于缩小癌症并减缓肿瘤的生长,然后对前列腺癌高复发率的患者进行治疗。激素治疗包括 LHRH 激动剂、拮抗剂、抗雄激素和其他抗雄激素阻断剂。治疗期间处方的激动剂药物包括亮丙瑞林、戈舍瑞林和曲普瑞林,其次是拮抗剂地加瑞克和瑞戈利克。雄激素药物包括比卡鲁胺、氟他胺、尼鲁胺、阿帕鲁胺等。接受激素治疗的患者经历的一些危险因素包括肌肉质量损失、性欲减退、紊乱、疲劳、体脂增加等等。接受激素治疗的患者应每月接受专科医生的监督,以避免并发症。

根据最终用户,市场分为医院、诊所和其他。 2022年,医院细分市场占据最大的前列腺癌治疗市场份额。预计 2022 年至 2030 年将创下最高复合年增长率。

最终用户的前列腺癌治疗市场 – 2022 年和 2030 年

区域分析:

前列腺癌治疗市场分为北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。预计 2022 年至 2030 年,亚太地区将创下市场最高复合年增长率。北美是前列腺癌治疗市场规模的最大贡献者。北美市场的增长归因于前列腺癌发病率的增加、产品发布数量的增加、主要市场参与者的存在以及政府支持前列腺癌病例治疗的举措。在北美,美国在 2022 年占据最大的市场份额。

行业发展和未来机遇:

前列腺癌治疗市场预测是根据各种继发性和原发性癌症估计的研究成果,例如主要公司出版物、协会数据和数据库。根据新闻稿,前列腺癌治疗市场主要参与者的策略如下:

2024 年 1 月,BDR Pharmaceuticals 在全球范围内首次推出前列腺癌药物恩杂鲁胺口服溶液形式。该配方提供了“一种有效的剂型,与现有的恩杂鲁胺口服剂型相比,副作用更小。”2023 年 11 月,安斯泰来制药公司和辉瑞公司宣布,两家公司获得了美国食品和药物管理局的批准。继 FDA 加快开发和审查计划后,药物管理局 (FDA) 批准了 XTANDI®(enzalutamide)的补充新药申请。2022 年 3 月,美国 FDA 批准诺华的 Pluvicto(镥 Lu177 vipivotide tetraxetan)用于治疗成人患者患有一种晚期前列腺癌——前列腺特异性膜抗原阳性转移性去势抵抗性前列腺癌(PSMA 阳性 mCRPC)。竞争格局和主要公司:

Astella Pharma Inc、礼来公司、拜耳AG、默克公司、赛诺菲、阿斯利康、强生服务公司、诺华公司、艾伯维和百时美施贵宝是前列腺癌治疗市场报告中介绍的知名参与者。此外,研究期间还对其他几家参与者进行了研究和分析,以全面了解市场及其生态系统。这些公司专注于地域扩张和新产品发布,以满足全球消费者不断增长的需求,并通过专业产品组合扩展其产品范围。他们的全球业务使他们能够为庞大的客户群提供服务。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Prostate Cancer Treatment Market

  1. Astella Pharma Inc
  2. Eli Lilly and Company
  3. Bayer AG
  4. Merck KGaA
  5. Sanofi
  6. AstraZeneca
  7. Johnson & Johnson Services Inc
  8. Novartis AG
  9. AbbVie
  10. Bristol Myers Squibb

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports